Viewing Study NCT00739505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-01-09 @ 4:33 PM
Study NCT ID: NCT00739505
Status: COMPLETED
Last Update Posted: 2019-03-29
First Post: 2008-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypophosphatasia (HPP) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypophosphatasia View
None Bone Disease View
None Soft Bones View
None Low Alkaline Phosphatase View
None genetic metabolic disorder View
None alkaline phosphatase View
None tissue non-specific alkaline phosphatase View
None rickets View
None osteomalacia View